t
IP Group plc announced on 21 May 2025 that it will hold a Capital Markets Event for investors and analysts on Thursday, June 26, 2025. CEO Greg Smith and CFOO David Baynes will host the event, featuring presentations from the Group and three portfolio companies (Hysata, Intrinsic, Genomics), with no material new information to be released.
| Date | 21 May 2025 |
| Time | 10:21:54 |
| Category | Miscellaneous |
| ID | 6001J |
|
FOR RELEASE ON |
21 May 2025 |
IP Group plc - Notice of Capital Markets Event
IP Group plc (LSE: IPO) ("IP Group" or "the Group"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, announces that it will hold a Capital Markets Event for investors and analysts on Thursday June 26, 2025.
The event, which will be hosted by CEO Greg Smith and CFOO David Baynes, will include presentations on the Group's investment strategy, pipeline, major themes and portfolio companies. In addition, the agenda will also include presentations from three portfolio companies, one from each of its three respective thematic sectors - Hysata (cleantech), Intrinsic (deeptech) and Genomics (life sciences).
Capital Markets Event details
The Capital Markets Event will be held at the offices of Deutsche Numis,
45 Gresham Street, London, EC2V 7BF and will start at 3pm. To register for the event, please email [email protected].
Further details can also be found on the events section of our website: https://www.ipgroupplc.com/news-and-events/events.
No material new information will be released by the Group during the presentation.
For more information, please contact:
|
IP Group plc |
www.ipgroupplc.com |
|
Liz Vaughan-Adams, Communications |
+44 (0) 20 7444 0062/+44 (0) 7967 312125 |
|
Portland |
|
|
Alex Donaldson |
+44 (0) 7516 729702 |
Notes for editors
About IP Group
IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science investor, we develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO. For more information, please visit our website at www.ipgroupplc.com.
ENDS